Gender and sex considerations in HIV and bone health

MJ Tang, A Alexander, JF Hoy - Current Opinion in HIV and AIDS, 2023 - journals.lww.com
More data is needed to determine changes in prevalence of osteopenia, osteoporosis, and
fractures in the era of immediate initiation of ART at high CD4 cell counts and the use of …

Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential

AC Henderson, P Cholli, MA Lampe… - Expert Review of Anti …, 2024 - Taylor & Francis
ABSTRACT Introduction The HIV/AIDS epidemic has been one of the greatest challenges in
global health, significantly affecting women of reproductive potential. Considerable …

Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial

T Vhembo, K Baltrusaitis, C Tierney… - JAIDS Journal of …, 2023 - journals.lww.com
Background: We assessed bone and kidney outcomes in infants randomized postdelivery as
mother–infant pairs within the IMPAACT PROMISE trial to maternal tenofovir disoproxil …

[HTML][HTML] Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP …

DJ Davey, S Dadan, K Bheemraj, C Waitt, S Khoo… - Antiviral Research, 2024 - Elsevier
Background There are few data on tenofovir-diphosphate (TFV-DP) concentrations in
pregnant and postpartum women on Tenofovir Disoproxil Fumarate-Emtricitabine (TDF-FTC) …

Biochemical Markers of Calcium and Bone Metabolism during and after Lactation in Ugandan Women with HIV on Universal Maternal Antiretroviral Therapy

F Nabwire, MM Hamill, MG Fowler… - Journal of Bone and …, 2023 - academic.oup.com
We reported accentuated lactational decreases in areal bone mineral density and only
partial skeletal recovery after lactation in Ugandan women with HIV (WWH) initiated on …

Impact of Tenofovir Disoproxil Fumarate Use During Pregnancy on Maternal Bone Mineral Density

L Wang, AP Kourtis, J Wiener, L Chen… - The Pediatric …, 2022 - journals.lww.com
Impact of Tenofovir Disoproxil Fumarate Use During Pregnancy... : The Pediatric Infectious
Disease Journal Impact of Tenofovir Disoproxil Fumarate Use During Pregnancy on Maternal …

Improving Pre-exposure Prophylaxis (PrEP) delivery for HIV prevention among women of reproductive age in Sub-Saharan Africa

K Zewdie - 2024 - search.proquest.com
Adolescent girls and young women in East and Southern Africa are disproportionately
affected by HIV. Tenofovir disoproxil fumarate (TDF)-based oral pre-exposure prophylaxis …

Evaluation of Pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in Pregnant and Postpartum Women in South Africa: PrEP-PP PK …

D Joseph Davey, S Dadan, K Bheemraj, C Waitt… - 2024 - escholarship.org
BackgroundThere are few data on tenofovir-diphosphate (TFV-DP) concentrations in
pregnant and postpartum women on Tenofovir Disoproxil Fumarate-Emtricitabine (TDF-FTC) …

The effect of HIV and its treatment on trabecular and cortical bone architecture in children, adolescents and premenopausal women

C Kahari - 2024 - researchonline.lshtm.ac.uk
INTRODUCTION: Understanding factors influencing bone accrual in childhood and bone
loss in early adulthood may inform approaches to improve skeletal health and reduce …

Markers of maternal bone and renal toxicity through 50 weeks postpartum: IMPAACT 2010 (VESTED) Trial

G Masheto, SS Brummel, L Ziemba… - JAIDS Journal of …, 2022 - journals.lww.com
Background: Safety data from randomized trials of antiretrovirals in pregnancy are scarce.
We evaluated maternal bone and renal data from IMPAACT 2010 trial, which compared the …